MX2021010552A - Nuevo peptido y uso del mismo. - Google Patents

Nuevo peptido y uso del mismo.

Info

Publication number
MX2021010552A
MX2021010552A MX2021010552A MX2021010552A MX2021010552A MX 2021010552 A MX2021010552 A MX 2021010552A MX 2021010552 A MX2021010552 A MX 2021010552A MX 2021010552 A MX2021010552 A MX 2021010552A MX 2021010552 A MX2021010552 A MX 2021010552A
Authority
MX
Mexico
Prior art keywords
present
novel peptide
effectively treating
preventing
insulitis
Prior art date
Application number
MX2021010552A
Other languages
English (en)
Inventor
Hae Jin Kim
Eun-Joung Moon
Young Hoon Lee
Original Assignee
Ensol Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ensol Biosciences Inc filed Critical Ensol Biosciences Inc
Publication of MX2021010552A publication Critical patent/MX2021010552A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)

Abstract

La presente invención se refiere a un péptido que consiste en la secuencia de aminoácidos de la SEQ ID NO: 1 o una sal farmacéuticamente aceptable del mismo y al uso del mismo. La presente invención es capaz de tratar o prevenir eficazmente la insulitis. Además, la presente invención es capaz de tratar o prevenir eficazmente la diabetes tipo 1.
MX2021010552A 2019-03-13 2020-03-05 Nuevo peptido y uso del mismo. MX2021010552A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190028654A KR101995768B1 (ko) 2019-03-13 2019-03-13 신규 펩타이드 및 그 용도
PCT/KR2020/003132 WO2020184901A1 (en) 2019-03-13 2020-03-05 Novel peptide and use thereof

Publications (1)

Publication Number Publication Date
MX2021010552A true MX2021010552A (es) 2021-10-01

Family

ID=67258723

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021010552A MX2021010552A (es) 2019-03-13 2020-03-05 Nuevo peptido y uso del mismo.

Country Status (10)

Country Link
US (1) US20220135621A1 (es)
EP (1) EP3938376A4 (es)
JP (1) JP7163547B2 (es)
KR (1) KR101995768B1 (es)
CN (1) CN113508126B (es)
AU (1) AU2020234373B9 (es)
BR (1) BR112021017625A2 (es)
CA (1) CA3132808A1 (es)
MX (1) MX2021010552A (es)
WO (1) WO2020184901A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101995768B1 (ko) * 2019-03-13 2019-07-03 (주)엔솔바이오사이언스 신규 펩타이드 및 그 용도
KR102624902B1 (ko) * 2023-08-24 2024-01-17 주식회사 엔솔바이오사이언스 노나펩타이드의 신규 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2709839B2 (ja) * 1987-12-25 1998-02-04 三井東圧化学株式会社 膵疾患等の予防・治療剤
KR20010081515A (ko) * 2000-02-15 2001-08-29 복성해 프로디지오신의 당뇨병 예방 및 치료용 조성물
WO2001070973A1 (fr) * 2000-03-24 2001-09-27 Japan As Represented By President Of Tokyo University Of Agriculture And Technology Precurseurs de matieres de type soie, matieres de type soie et procede de production desdits precurseurs et desdites matieres
US20100256061A1 (en) * 2007-03-02 2010-10-07 Antonio Cruz Gastrin compound for diabetes treatment
BRPI0815308A2 (pt) * 2007-08-30 2016-07-19 Curedm Inc peptídeo das pró-ilhotas de lagerhans, composição farmacûtica, método para estimular na neogêneses das ilhotas ou estimular a regeneração das ilhotas de langerhans e método para tratar uma patologia associada com a função pancreática defeituosa em um indivíduo
KR100983182B1 (ko) * 2009-08-14 2010-09-20 (주)엔솔테크 신규 펩타이드 및 그 용도
KR101029705B1 (ko) * 2010-06-30 2011-04-18 (주)엔솔테크 신규 펩타이드 및 그 용도
EP2956475A4 (en) * 2013-02-15 2016-11-16 Univ Mcgill MODIFIED INGAP PEPTIDES FOR THE TREATMENT OF DIABETES
CA2910044A1 (en) * 2013-04-26 2014-10-30 Philogen S.P.A. Il4 conjugated to antibodies against extracellular matrix components
CN104059131A (zh) * 2014-07-04 2014-09-24 丝科普乐（北京）生物科技有限公司 抗丝素蛋白多克隆抗体及其制备方法
KR101644982B1 (ko) * 2015-07-23 2016-08-02 주식회사 엔솔바이오사이언스 신규 펩타이드 및 그 용도
KR101909052B1 (ko) * 2017-02-09 2018-10-17 강원대학교산학협력단 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물
KR101995768B1 (ko) * 2019-03-13 2019-07-03 (주)엔솔바이오사이언스 신규 펩타이드 및 그 용도

Also Published As

Publication number Publication date
AU2020234373B9 (en) 2022-06-23
US20220135621A1 (en) 2022-05-05
WO2020184901A1 (en) 2020-09-17
CN113508126A (zh) 2021-10-15
EP3938376A4 (en) 2023-03-29
BR112021017625A2 (pt) 2021-11-09
JP2022524585A (ja) 2022-05-09
AU2020234373B2 (en) 2022-05-12
AU2020234373A1 (en) 2021-09-30
CA3132808A1 (en) 2020-09-17
AU2020234373A9 (en) 2021-10-14
CN113508126B (zh) 2023-09-29
EP3938376A1 (en) 2022-01-19
KR101995768B1 (ko) 2019-07-03
JP7163547B2 (ja) 2022-11-01

Similar Documents

Publication Publication Date Title
NZ621196A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
MX2012008999A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340015B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX342291B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340016B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
WO2019045248A3 (ko) 주름 개선 활성을 나타내는 펩타이드 및 이의 용도
RU2011106744A (ru) Инсулин, стабилизированный галогеном
MX339277B (es) Agente inductor de inmunidad.
DK1795598T3 (da) Hidtil ukendte peptider
NZ711037A (en) Peptides and compositions for treatment of joint damage
NZ599161A (en) Method for activation of helper t cell and composition for use in the method
MX2021010552A (es) Nuevo peptido y uso del mismo.
WO2018155813A3 (ko) 엔테로코쿠스 패슘에 대하여 용균력을 가지는 신규한 항균단백질 efal-2
MX2021014497A (es) Peptidos.
NZ756128A (en) Novel peptides and analogs for use in the treatment of oral mucositis
NZ614557A (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
NZ736652A (en) Short synthetic peptide for treating diseases and/or conditions related to angiogenesis
MX2023002087A (es) Agonistas del receptor crf2 y su uso en terapia.
MX2021004879A (es) Peptido inhibidor de calicreina 5 (klk5).
EA202090802A1 (ru) Пептидная композиция для лечения повреждений, связанных с возбуждающей нейротоксичностью
MX2020010422A (es) Alfa-amilasa maltogenica variante.
WO2019059572A3 (ko) 홍어 껍질 유래의 신규한 항균 펩타이드 및 이의 용도
ZA202205158B (en) Polypeptide having mmp2-inhibitory effect
NZ583429A (en) Peptides and proteins capable of inhibiting and/or preventing mast cell activation
MX2020007336A (es) Metodos y composiciones para modular la disfuncion de celulas endoteliales.